Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Progress in Lipid Research

Volumn 50, Issue 2, 2011, Pages 193-211

  Pacher, P ^a   Mechoulam, R ^b  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cannabinoid 1 and 2 receptors; Disease; Endocannabinoids; Immune function; Inflammation

Indexed keywords

1 (2,3 DICHLOROBENZOYL) 5 METHOXY 2 METHYL 3 (2 MORPHOLINOETHYL)INDOLE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID 2 RECEPTOR; DESIPRAMINE; DEXANABINOL; ENDOCANNABINOID; LIPID;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; ASTHMA; ATHEROSCLEROSIS; BONE DISEASE; CARDIOMYOPATHY; CIRRHOTIC CARDIOMYOPATHY; DEPRESSION; ENTERITIS; EYE DISEASE; GENITAL SYSTEM DISEASE; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEPATIC ENCEPHALOPATHY; HEPATITIS; HUMAN; HUNTINGTON CHOREA; ISCHEMIC PRECONDITIONING; KIDNEY DISEASE; LIPID ANALYSIS; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LOW DRUG DOSE; MALIGNANT NEOPLASTIC DISEASE; METABOLIC DISORDER; MULTIPLE SCLEROSIS; NONHUMAN; PAIN; PANCREATITIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; RESTENOSIS; REVIEW; RHEUMATOID ARTHRITIS; SCHIZOPHRENIA; SCLERODERMA; SEPTIC SHOCK; SIGNAL TRANSDUCTION; SKIN ALLERGY; STROKE;

ENDOCANNABINOIDS; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LIPID METABOLISM; RECEPTOR, CANNABINOID, CB2; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 79952198989     PISSN: 01637827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plipres.2011.01.001     Document Type: Review

References (286)

1. P. Pacher, P. Mukhopadhyay, R. Mohanraj, G. Godlewski, S. Batkai, and G. Kunos Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations Hypertension 52 2008 601 607
2. P. Pacher, and S. Steffens The emerging role of the endocannabinoid system in cardiovascular disease Semin Immunopathol 31 2009 63 77
3. A.A. Izzo, and M. Camilleri Cannabinoids in intestinal inflammation and cancer Pharmacol Res 60 2009 117 125
4. A.A. Izzo, and K.A. Sharkey Cannabinoids and the gut: new developments and emerging concepts Pharmacol Ther 126 2010 21 38
5. A. Mallat, and S. Lotersztajn Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver Am J Physiol Gastrointest Liver Physiol 294 2008 G9 G12
6. 2 receptors as new therapeutic targets for liver diseases Br J Pharmacol 153 2008 286 289
7. P. Pacher, and B. Gao Endocannabinoids and liver disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases Am J Physiol Gastrointest Liver Physiol 294 2008 G850 G854
8. P. Mukhopadhyay, M. Rajesh, H. Pan, V. Patel, B. Mukhopadhyay, and S. Batkai Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy Free Radic Biol Med 48 2010 457 467
9. 1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model Br J Pharmacol 160 2010 657 668
10. P. Pacher, S. Batkai, and G. Kunos The endocannabinoid system as an emerging target of pharmacotherapy Pharmacol Rev 58 2006 389 462 (Pubitemid 44394908)
11. D. Centonze, A. Finazzi-Agro, G. Bernardi, and M. Maccarrone The endocannabinoid system in targeting inflammatory neurodegenerative diseases Trends Pharmacol Sci 28 2007 180 187 (Pubitemid 46483718)
12. 2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28 2007 39 45 (Pubitemid 46038536)
13. 2 receptors in the brain: role in central immune function Br J Pharmacol 153 2008 240 251
14. J. Fernandez-Ruiz The endocannabinoid system as a target for the treatment of motor dysfunction Br J Pharmacol 156 2009 1029 1040
15. 2 receptor in schizophrenia Biol Psychiatry 67 2010 974 982
16. 2 receptor antagonist, AM630, on isolation rearing - induced behavioural deficits in rats Schizophr Res 117 2010 391 392
17. 2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression Ann NY Acad Sci 1139 2008 434 449
18. M.S. Garcia-Gutierrez, J.M. Perez-Ortiz, A. Gutierrez-Adan, and J. Manzanares Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors Br J Pharmacol 160 2010 1773 1784
19. 2-selective agonist GW405833 Pain 143 2009 206 212
20. 2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice J Psychopharmacol 25 1 2011 111 120
21. 2 receptors and the endocannabinoid system for the treatment of pain Brain Res Rev 60 2009 255 266
22. 2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain Br J Pharmacol 153 2008 319 334
23. M. Guzman Cannabinoids: potential anticancer agents Nat Rev Cancer 3 2003 745 755 (Pubitemid 37328813)
24. S. Pisanti, and M. Bifulco Endocannabinoid system modulation in cancer biology and therapy Pharmacol Res 60 2009 107 116
25. N. Stella Cannabinoid and cannabinoid-like receptors in microglia, astrocytes, and astrocytomas Glia 58 2010 1017 1030
26. C.J. Fowler, S.B. Gustafsson, S.C. Chung, E. Persson, S.O. Jacobsson, and A. Bergh Targeting the endocannabinoid system for the treatment of cancer - a practical view Curr Top Med Chem 10 2010 814 827
27. I. Bab, and A. Zimmer Cannabinoid receptors and the regulation of bone mass Br J Pharmacol 153 2008 182 188
28. I. Bab, A. Zimmer, and E. Melamed Cannabinoids and the skeleton: from marijuana to reversal of bone loss Ann Med 41 2009 560 567
29. 2 receptors in reproduction Br J Pharmacol 153 2008 189 198
30. M. Maccarrone Endocannabinoids: friends and foes of reproduction Prog Lipid Res 48 2009 344 354
31. 2 receptor in mouse spermatogenesis Proc Natl Acad Sci USA 106 2009 11131 11136
32. T. Biro, B.I. Toth, G. Hasko, R. Paus, and P. Pacher The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities Trends Pharmacol Sci 30 2009 411 420
33. R. Mechoulam, and L. Hanus A historical overview of chemical research on cannabinoids Chem Phys Lipids 108 2000 1 13
34. Y. Gaoni, and R. Mechoulam Isolation, structure and partial synthesis of an active constituent of hashish J Am Chem Soc 86 1964 1646 1647
35. E.W. Gill, and D.K. Lawrence The physiological mode of action of tetrahydrocannabinol on cell membranes Pharmacol Marihuana 1 1976 147 155
36. R. Mechoulam, J.J. Feigenbaum, N. Lander, M. Segal, T.U. Jarbe, and A.J. Hiltunen Enantiomeric cannabinoids: stereospecificity of psychotropic activity Experientia 44 1988 762 764
37. W.A. Devane, F.A. Dysarz 3rd, M.R. Johnson, L.S. Melvin, and A.C. Howlett Determination and characterization of a cannabinoid receptor in rat brain Mol Pharmacol 34 1988 605 613 (Pubitemid 19007296)
38. L.A. Matsuda, S.J. Lolait, M.J. Brownstein, A.C. Young, and T.I. Bonner Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346 1990 561 564
39. S. Munro, K.L. Thomas, and M. Abu-Shaar Molecular characterization of a peripheral receptor for cannabinoids Nature 365 1993 61 65 (Pubitemid 23305569)
40. G. Godlewski, L. Offertaler, J.A. Wagner, and G. Kunos Receptors for acylethanolamides-GPR55 and GPR119 Prostaglandins Other Lipid Mediat 89 2009 105 111
41. V. Di Marzo, M. Bifulco, and L. De Petrocellis The endocannabinoid system and its therapeutic exploitation Nat Rev Drug Discov 3 2004 771 784 (Pubitemid 39242829)
42. 2 Pharmacol Rev 62 2010 588 631
43. Brown AJ, Daniels DA, Kassim M, Brown S, Haslam CP, Terrell VR, et al. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity GlyT1 inhibitor and GPR55 agonist. J Pharmacol Exp Ther, in press. doi:10.1124/jpet.110.172650.
44. A. Szallasi, and P.M. Blumberg Vanilloid (Capsaicin) receptors and mechanisms Pharmacol Rev 51 1999 159 212
45. V. Di Marzo, and L. De Petrocellis Endocannabinoids as regulators of transient receptor potential (TRP) channels: a further opportunity to develop new endocannabinoid-based therapeutic drugs Curr Med Chem 17 2010 1430 1449
46. B.A. Grueter, G. Brasnjo, and R.C. Malenka Postsynaptic TRPV1 triggers cell type-specific long-term depression in the nucleus accumbens Nat Neurosci 13 2010 1519 1525
47. A.E. Chavez, C.Q. Chiu, and P.E. Castillo TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus Nat Neurosci 13 2010 1511 1518
48. V. Di Marzo Anandamide serves two masters in the brain Nat Neurosci 13 2010 1446 1448
49. A.C. Howlett, F. Barth, T.I. Bonner, G. Cabral, P. Casellas, and W.A. Devane International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 2002 161 202 (Pubitemid 34575709)
50. 2: a cannabinoid receptor with an identity crisis Br J Pharmacol 160 2010 467 479
51. 2 receptors Science 310 2005 329 332 (Pubitemid 41457202)
52. C. Borner, M. Smida, V. Hollt, B. Schraven, and J. Kraus Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling J Biol Chem 284 2009 35450 35460
53. W.A. Devane, L. Hanus, A. Breuer, R.G. Pertwee, L.A. Stevenson, and G. Griffin Isolation and structure of a brain constituent that binds to the cannabinoid receptor Science 258 1992 1946 1949 (Pubitemid 23026736)
54. W.A. Devane, A. Breuer, T. Sheskin, T.U. Jarbe, M.S. Eisen, and R. Mechoulam A novel probe for the cannabinoid receptor J Med Chem 35 1992 2065 2069
55. R. Mechoulam, S. Ben-Shabat, L. Hanus, M. Ligumsky, N.E. Kaminski, and A.R. Schatz Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem Pharmacol 50 1995 83 90
56. T. Sugiura, S. Kondo, A. Sukagawa, S. Nakane, A. Shinoda, and K. Itoh 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem Biophys Res Commun 215 1995 89 97
57. D. Piomelli The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 2003 873 884 (Pubitemid 37351427)
58. L.O. Hanus, and R. Mechoulam Novel natural and synthetic ligands of the endocannabinoid system Curr Med Chem 17 2010 1341 1359
59. J. Wang, and N. Ueda Biology of endocannabinoid synthesis system Prostaglandins Other Lipid Mediat 89 2009 112 119
60. B.F. Cravatt, and A.H. Lichtman The enzymatic inactivation of the fatty acid amide class of signaling lipids Chem Phys Lipids 121 2002 135 148 (Pubitemid 36044548)
61. M.K. McKinney, and B.F. Cravatt Structure and function of fatty acid amide hydrolase Annu Rev Biochem 74 2005 411 432 (Pubitemid 40995513)
62. F. Fezza, C. De Simone, D. Amadio, and M. Maccarrone Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system Subcell Biochem 49 2008 101 132
63. V. Di Marzo Targeting the endocannabinoid system: to enhance or reduce? Nat Rev Drug Discov 7 2008 438 455 (Pubitemid 351649182)
64. S. Brogi, F. Corelli, V. Di Marzo, A. Ligresti, C. Mugnaini, and S. Pasquini Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2 Eur J Med Chem 46 2 2011 547 555
65. 2 receptor inhibitors Bioorg Med Chem Lett 20 2010 608 611
66. 2 receptor ligands Bioorg Med Chem Lett 20 2010 6785 6789
67. G.A. Thakur, R. Tichkule, S. Bajaj, and A. Makriyannis Latest advances in cannabinoid receptor agonists Expert Opin Ther Pat 19 2009 1647 1673
68. 2 receptor subtype selectivity limits of 1,2-diarylimidazole-4- carboxamides by fine-tuning their 5-substitution pattern Bioorg Med Chem Lett 20 2010 2770 2775
69. 2 receptor-specific inverse agonists Curr Top Med Chem 10 2010 768 778
70. R.G. Pertwee Pharmacological actions of cannabinoids Handb Exp Pharmacol 2005 1 51
71. 2 receptor ligands Mini Rev Med Chem 5 2005 641 649 (Pubitemid 40933035)
72. J.L. Wiley, I.D. Beletskaya, E.W. Ng, Z. Dai, P.J. Crocker, and A. Mahadevan Resorcinol derivatives: a novel template for the development of cannabinoid CB(1)/CB(2) and CB(2)-selective agonists J Pharmacol Exp Ther 301 2002 679 689 (Pubitemid 34429984)
73. M. Zhang, B.R. Martin, M.W. Adler, R.K. Razdan, J.I. Jallo, and R.F. Tuma Cannabinoid CB(2) receptor activation decreases cerebral infarction in a mouse focal ischemia/reperfusion model J Cereb Blood Flow Metab 27 2007 1387 1396 (Pubitemid 46985356)
74. 2 cannabinoid ligand 1-(2′,4′- dichlorophenyl)-6-methyl-N-piperidin-1-yl-1,4-dihydroindeno[1,2-c] pyrazole-3-carboxamide J Med Chem 49 2006 7502 7512 (Pubitemid 44913409)
75. K.J. Valenzano, L. Tafesse, G. Lee, J.E. Harrison, J.M. Boulet, and S.L. Gottshall Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy Neuropharmacology 48 2005 658 672 (Pubitemid 40462406)
76. T.W. Klein, C. Newton, K. Larsen, L. Lu, I. Perkins, and L. Nong The cannabinoid system and immune modulation J Leukoc Biol 74 2003 486 496 (Pubitemid 38040375)
77. T.W. Klein Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5 2005 400 411 (Pubitemid 40685989)
78. V. Di Marzo, and S. Petrosino Endocannabinoids and the regulation of their levels in health and disease Curr Opin Lipidol 18 2007 129 140 (Pubitemid 46412082)
79. G.A. Cabral, and A. Staab Effects on the immune system Handb Exp Pharmacol 2005 385 423
80. 2 receptors PLoS One 5 2010 e8688
81. 2 receptor-mediated migration of immune cells: it can go either way Br J Pharmacol 153 2008 299 308
82. N.E. Buckley The peripheral cannabinoid receptor knockout mice: an update Br J Pharmacol 153 2008 309 318
83. P. Pacher, J.S. Beckman, and L. Liaudet Nitric oxide and peroxynitrite in health and disease Physiol Rev 87 2007 315 424 (Pubitemid 46217686)
84. S. Jiang, M. Alberich-Jorda, R. Zagozdzon, K. Parmar, Y. Fu, and P. Mauch Cannabinoid receptor 2 and its agonists mediate hematopoiesis and hematopoietic stem and progenitor cell mobilization Blood 117 2011 827 838
85. 2 receptors in the brain Neuropsychobiology 54 2006 231 246
86. M. Beltramo Cannabinoid type 2 receptor as a target for chronic - pain Mini Rev Med Chem 9 2009 11 25
87. 2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation Br J Pharmacol 153 2008 263 270
88. L. Marquez, J. Suarez, M. Iglesias, F.J. Bermudez-Silva, F. Rodriguez de Fonseca, and M. Andreu Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue PLoS One 4 2009 e6893
89. 2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats Am J Physiol Gastrointest Liver Physiol 295 2008 G78 G87
90. C. Rousseaux, X. Thuru, A. Gelot, N. Barnich, C. Neut, and L. Dubuquoy Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors Nat Med 13 2007 35 37 (Pubitemid 46067383)
91. I. Bab, O. Ofek, J. Tam, J. Rehnelt, and A. Zimmer Endocannabinoids and the regulation of bone metabolism J Neuroendocrinol 20 Suppl. 1 2008 69 74 (Pubitemid 351552679)
92. 1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity J Am Coll Cardiol 50 2007 528 536 (Pubitemid 47126779)
93. 1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes Cardiovasc Res 85 2010 773 784
94. J.F. Bouchard, P. Lepicier, and D. Lamontagne Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart Life Sci 72 2003 1859 1870 (Pubitemid 36174022)
95. 2 cannabinoid receptor agonists attenuate TNF-alpha-induced human vascular smooth muscle cell proliferation and migration Br J Pharmacol 153 2008 347 357
96. 2 in the liver Gastroenterology 128 2005 742 755 (Pubitemid 40585376)
97. K.M. Starowicz, L. Cristino, I. Matias, R. Capasso, A. Racioppi, and A.A. Izzo Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet Obesity (Silver Spring) 16 2008 553 565 (Pubitemid 351328005)
98. C.W. Michalski, T. Laukert, D. Sauliunaite, P. Pacher, F. Bergmann, and N. Agarwal Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis Gastroenterology 132 2007 1968 1978 (Pubitemid 46695719)
99. C.W. Michalski, M. Maier, M. Erkan, D. Sauliunaite, F. Bergmann, and P. Pacher Cannabinoids reduce markers of inflammation and fibrosis in pancreatic stellate cells PLoS One 3 2008 e1701
100. F.J. Bermudez-Silva, J. Suarez, E. Baixeras, N. Cobo, D. Bautista, and A.L. Cuesta-Munoz Presence of functional cannabinoid receptors in human endocrine pancreas Diabetologia 51 2008 476 487
101. C. Petrella, S. Agostini, G.S. Alema, P. Casolini, F. Carpino, and C. Giuli Cannabinoid agonist WIN55, 212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis Neurogastroenterol Motil 11 2010 1248 1256
102. 2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion Am J Physiol Heart Circ Physiol 293 2007 H2210 H2218
103. M. Rajesh, H. Pan, P. Mukhopadhyay, S. Batkai, D. Osei-Hyiaman, and G. Hasko Cannabinoid-2 receptor agonist HU-308 protects against hepatic ischemia/reperfusion injury by attenuating oxidative stress, inflammatory response, and apoptosis J Leukoc Biol 82 2007 1382 1389 (Pubitemid 350276948)
104. M. Bari, N. Battista, V. Pirazzi, and M. Maccarrone The manifold actions of endocannabinoids on female and male reproductive events Front Biosci 16 2011 498 516
105. 2, regulates bone mass Proc Natl Acad Sci USA 103 2006 696 701 (Pubitemid 43153088)
106. 2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN J Leukoc Biol 75 2004 453 459 (Pubitemid 38316376)
107. P. Pacher, and G. Hasko Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning Br J Pharmacol 153 2008 252 262
108. F. Montecucco, S. Lenglet, V. Braunersreuther, F. Burger, G. Pelli, and M. Bertolotto CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion J Mol Cell Cardiol 46 2009 612 620
109. N. Defer, J. Wan, R. Souktani, B. Escoubet, M. Perier, and P. Caramelle The cannabinoid receptor type 2 promotes cardiac myocyte and fibroblast survival and protects against ischemia/reperfusion-induced cardiomyopathy FASEB J 23 2009 2120 2130
110. D. Lamontagne, P. Lepicier, C. Lagneux, and J.F. Bouchard The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia Arch Mal Coeur Vaiss 99 2006 242 246 (Pubitemid 46211438)
111. F. Montecucco, I. Matias, S. Lenglet, S. Petrosino, F. Burger, and G. Pelli Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis Atherosclerosis 205 2009 433 441
112. F. Mach, and S. Steffens The role of the endocannabinoid system in atherosclerosis J Neuroendocrinol 20 Suppl. 1 2008 53 57 (Pubitemid 351552677)
113. S. Steffens, N.R. Veillard, C. Arnaud, G. Pelli, F. Burger, and C. Staub Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice Nature 434 2005 782 786 (Pubitemid 44739523)
114. 2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules J Cardiovasc Pharmacol 55 2010 292 298
115. 2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways Am J Physiol Heart Circ Physiol 294 2008 H1145 H1155
116. 2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases Am J Physiol Heart Circ Physiol 294 2008 H1133 H1134
117. K. Sugamura, S. Sugiyama, T. Nozaki, Y. Matsuzawa, Y. Izumiya, and K. Miyata Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages Circulation 119 2009 28 36
118. M. Naccarato, D. Pizzuti, S. Petrosino, M. Simonetto, L. Ferigo, and F.C. Grandi Possible Anandamide and Palmitoylethanolamide involvement in human stroke Lipids Health Dis 9 2010 47
119. C.J. Hillard Role of cannabinoids and endocannabinoids in cerebral ischemia Curr Pharm Des 14 2008 2347 2361
120. 1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia Neuroscience 129 2004 743 750 (Pubitemid 39487125)
121. 2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury Microvasc Res 78 2009 86 94
122. M. Zhang, B.R. Martin, M.W. Adler, R.K. Razdan, D. Ganea, and R.F. Tuma Modulation of the balance between cannabinoid CB(1) and CB(2) receptor activation during cerebral ischemic/reperfusion injury Neuroscience 152 2008 753 760
123. 2 receptor activation attenuates motor and autonomic function deficits in a mouse model of spinal cord injury Clin Neurosurg 55 2008 172 177
124. S. Murikinati, E. Juttler, T. Keinert, D.A. Ridder, S. Muhammad, and Z. Waibler Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment FASEB J 24 2010 788 798
125. F. Weis, A. Beiras-Fernandez, R. Sodian, I. Kaczmarek, B. Reichart, and A. Beiras Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure J Mol Cell Cardiol 48 2010 1187 1193
126. S. Kohro, H. Imaizumi, M. Yamakage, Y. Masuda, A. Namiki, and Y. Asai Reductions in levels of bacterial superantigens/cannabinoids by plasma exchange in a patient with severe toxic shock syndrome Anaesth Intensive Care 32 2004 588 591 (Pubitemid 39172468)
127. S. Kohro, H. Imaizumi, M. Yamakage, Y. Masuda, A. Namiki, and Y. Asai Anandamide absorption by direct hemoperfusion with polymixin B-immobilized fiber improves the prognosis and organ failure assessment score in patients with sepsis J Anesth 20 2006 11 16 (Pubitemid 43125774)
128. 2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis PLoS One 4 2009 e6409
129. J. Tschop, K.R. Kasten, R. Nogueiras, H.S. Goetzman, C.M. Cave, and L.G. England The cannabinoid receptor 2 is critical for the host response to sepsis J Immunol 183 2009 499 505
130. M. Kurabayashi, I. Takeyoshi, D. Yoshinari, K. Matsumoto, I. Maruyama, and Y. Morishita 2-Arachidonoylglycerol increases in ischemia-reperfusion injury of the rat liver J Invest Surg 18 2005 25 31 (Pubitemid 40361163)
131. S. Batkai, D. Osei-Hyiaman, H. Pan, O. El-Assal, M. Rajesh, and P. Mukhopadhyay Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury FASEB J 21 2007 1788 1800 (Pubitemid 46855625)
132. Y. Ishii, T. Sakamoto, R. Ito, and K. Yanaga F2-isoprostanes and 2-arachidonylglycerol as biomarkers of lipid peroxidation in pigs with hepatic ischemia/reperfusion injury J Surg Res 161 2010 139 145
133. V.L. Hegde, S. Hegde, B.F. Cravatt, L.J. Hofseth, M. Nagarkatti, and P.S. Nagarkatti Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells Mol Pharmacol 74 2008 20 33 (Pubitemid 351872155)
134. R. Pandey, K. Mousawy, M. Nagarkatti, and P. Nagarkatti Endocannabinoids and immune regulation Pharmacol Res 60 2009 85 92
135. 2 in nonalcoholic fatty liver disease Liver Int 27 2007 215 219 (Pubitemid 46680725)
136. 2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis PLoS One 4 2009 e5844
137. 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity J Clin Invest 115 2005 1298 1305 (Pubitemid 40629049)
138. 2 cannabinoid receptor in mice improves insulin sensitivity but increases food intake and obesity with age Diabetologia 53 2010 2629 2640
139. 1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats Am J Physiol Heart Circ Physiol 293 2007 H1689 H1695
140. S.V. Siegmund, and R.F. Schwabe Endocannabinoids and liver disease. II. Endocannabinoids in the pathogenesis and treatment of liver fibrosis Am J Physiol Gastrointest Liver Physiol 294 2008 G357 G362
141. 2 receptor in cirrhotic rats J Pharmacol Exp Ther 324 2008 475 483 (Pubitemid 351185849)
142. 1 receptors mediate the vasodilated state in advanced liver cirrhosis Nat Med 7 2001 827 832 (Pubitemid 32691638)
143. L. Moezi, S.A. Gaskari, and S.S. Lee Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis Am J Physiol Gastrointest Liver Physiol 295 2008 G649 G653
144. S. Batkai, and P. Pacher Endocannabinoids and cardiac contractile function: pathophysiological implications Pharmacol Res 60 2009 99 106
145. F. Teixeira-Clerc, M.P. Belot, S. Manin, V. Deveaux, T. Cadoudal, and M.N. Chobert Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration Hepatology 52 3 2010 1046 1059
146. Y. Avraham, E. Israeli, E. Gabbay, A. Okun, O. Zolotarev, and I. Silberman Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice Neurobiol Dis 21 2006 237 245 (Pubitemid 41817322)
147. Y. Dagon, Y. Avraham, Y. Ilan, R. Mechoulam, and E.M. Berry Cannabinoids ameliorate cerebral dysfunction following liver failure via AMP-activated protein kinase FASEB J 21 2007 2431 2441 (Pubitemid 47230673)
148. I. Magen, Y. Avraham, E. Berry, and R. Mechoulam Endocannabinoids in liver disease and hepatic encephalopathy Curr Pharm Des 14 2008 2362 2369
149. F. Borrelli, and A.A. Izzo Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance Best Pract Res Clin Endocrinol Metab 23 2009 33 49
150. K. Wright, N. Rooney, M. Feeney, J. Tate, D. Robertson, and M. Welham Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing Gastroenterology 129 2005 437 453 (Pubitemid 41096632)
151. E.S. Kimball, C.R. Schneider, N.H. Wallace, and P.J. Hornby Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium Am J Physiol Gastrointest Liver Physiol 291 2006 G364 G371
152. 2) protects against experimental colitis Inflamm Bowel Dis 15 2009 1678 1685
153. 2 receptors J Mol Med 86 2008 925 936
154. M. Karsak, M. Cohen-Solal, J. Freudenberg, A. Ostertag, C. Morieux, and U. Kornak Cannabinoid receptor type 2 gene is associated with human osteoporosis Hum Mol Genet 14 2005 3389 3396 (Pubitemid 41672123)
155. A.I. Idris, R.J. van 't Hof, I.R. Greig, S.A. Ridge, D. Baker, and R.A. Ross Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors Nat Med 11 2005 774 779 (Pubitemid 41021210)
156. R. Smoum, A. Bar, B. Tan, G. Milman, M. Attar-Namdar, and O. Ofek Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass Proc Natl Acad Sci USA 107 2010 17710 17715
157. 2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains J Neurosci 23 2003 11136 11141 (Pubitemid 37548949)
158. 2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis J Neurosci 27 2007 2396 2402 (Pubitemid 46340977)
159. B.G. Ramirez, C. Blazquez, T. Gomez del Pulgar, M. Guzman, and M.L. de Ceballos Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation J Neurosci 25 2005 1904 1913 (Pubitemid 40289395)
160. 2 receptor in microglial cells in response to inflammatory stimuli J Neurochem 95 2005 437 445 (Pubitemid 41457512)
161. 2 on autoreactive T cells Nat Med 13 2007 492 497 (Pubitemid 46559830)
162. 2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis Eur J Pharmacol 542 2006 100 105 (Pubitemid 44096919)
163. 2 cannabinoid agonist AM-1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onset J Neurochem 101 2007 87 98 (Pubitemid 46426470)
164. D.A. Price, A.A. Martinez, A. Seillier, W. Koek, Y. Acosta, and E. Fernandez WIN55, 212-2, a cannabinoid receptor agonist, protects against nigrostriatal cell loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease Eur J Neurosci 29 2009 2177 2186
165. 2 receptors in human brain inflammation Br J Pharmacol 153 2008 277 285
166. 2 cannabinoid receptors are neuroprotective in Huntington's disease excitotoxicity Brain 132 2009 3152 3164
167. J. Palazuelos, N. Davoust, B. Julien, E. Hatterer, T. Aguado, and R. Mechoulam The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis J Biol Chem 283 2008 13320 13329
168. 2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease Glia 57 2009 1154 1167
169. 2 receptors stimulates in situ and in vitro beta-amyloid removal by human macrophages Brain Res 1283 2009 148 154
170. Z. De March, C. Zuccato, C. Giampa, S. Patassini, M. Bari, and V. Gasperi Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions Neuroscience 152 2008 734 740
171. L. Mestre, F. Docagne, F. Correa, F. Loria, M. Hernangomez, and J. Borrell A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules Mol Cell Neurosci 40 2009 258 266
172. F. Loria, S. Petrosino, M. Hernangomez, L. Mestre, A. Spagnolo, and F. Correa An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis Neurobiol Dis 37 2010 166 176
173. R.G. Pertwee The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids AAPS J 7 2005 E625 E654
174. T. Bisogno, and V. Di Marzo Cannabinoid receptors and endocannabinoids: role in neuroinflammatory and neurodegenerative disorders CNS Neurol Disord Drug Targets 9 5 2010 564 573
175. C.J. Fowler, M.L. Rojo, and A. Rodriguez-Gaztelumendi Modulation of the endocannabinoid system: neuroprotection or neurotoxicity? Exp Neurol 224 2010 37 47
176. 2 receptor agonist in a murine model of neuroAIDS J Neuroimmune Pharmacol 5 2010 456 468
177. A. Calignano, G. La Rana, A. Giuffrida, and D. Piomelli Control of pain initiation by endogenous cannabinoids Nature 394 1998 277 281 (Pubitemid 28335039)
178. L. Hanus, A. Breuer, S. Tchilibon, S. Shiloah, D. Goldenberg, and M. Horowitz HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor Proc Natl Acad Sci USA 96 1999 14228 14233 (Pubitemid 30000633)
179. 2 cannabinoid receptor-mediated peripheral antinociception Pain 93 2001 239 245 (Pubitemid 32763181)
180. 2 cannabinoid receptors are implicated in inflammatory pain Pain 96 2002 253 260 (Pubitemid 34327871)
181. 2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS Proc Natl Acad Sci USA 100 2003 10529 10533 (Pubitemid 37071912)
182. 2 cannabinoid receptor activation produces antinociception by stimulating peripheral release of endogenous opioids Proc Natl Acad Sci USA 102 2005 3093 3098 (Pubitemid 40299921)
183. 2 cannabinoid receptor mediation of antinociception Pain 122 2006 36 42
184. A.G. Nackley, A. Makriyannis, and A.G. Hohmann Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 119 2003 747 757 (Pubitemid 36694801)
185. A.G. Nackley, R.L. Suplita 2nd, and A.G. Hohmann A peripheral cannabinoid mechanism suppresses spinal fos protein expression and pain behavior in a rat model of inflammation Neuroscience 117 2003 659 670 (Pubitemid 36263159)
186. 2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation J Neurophysiol 92 2004 3562 3574 (Pubitemid 39506332)
187. 2 cannabinoid receptors Anesthesiology 99 2003 955 960 (Pubitemid 37186088)
188. 2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naive rats and in rat models of inflammatory and neuropathic pain Eur J Neurosci 20 2004 2311 2320 (Pubitemid 39472394)
189. 2 receptors suppresses hyperalgesia evoked by intradermal capsaicin J Pharmacol Exp Ther 308 2004 446 453 (Pubitemid 38134203)
190. D.A. Scott, C.E. Wright, and J.A. Angus Evidence that CB-1 and CB-2 cannabinoid receptors mediate antinociception in neuropathic pain in the rat Pain 109 2004 124 131 (Pubitemid 38479778)
191. 2 receptor agonists Curr Med Chem 14 2007 917 936 (Pubitemid 46863619)
192. 2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats J Pharmacol Exp Ther 327 2008 584 591
193. E.J. Rahn, and A.G. Hohmann Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside Neurotherapeutics 6 2009 713 737
194. K.R. Muller-Vahl, and H.M. Emrich Cannabis and schizophrenia: towards a cannabinoid hypothesis of schizophrenia Expert Rev Neurother 8 2008 1037 1048 (Pubitemid 351962072)
195. S. Andreasson, P. Allebeck, A. Engstrom, and U. Rydberg Cannabis and schizophrenia. A longitudinal study of Swedish conscripts Lancet 2 1987 1483 1486
196. N. De Marchi, L. De Petrocellis, P. Orlando, F. Daniele, F. Fezza, and V. Di Marzo Endocannabinoid signalling in the blood of patients with schizophrenia Lipids Health Dis 2 2003 5
197. L. Grinspoon, and J.B. Bakalar Marihuana as medicine. A plea for reconsideration JAMA 273 1995 1875 1876
198. L. Grinspoon, J.B. Bakalar, L. Zimmer, and J.P. Morgan Marijuana addiction Science 277 1997 749 author reply 50-2
199. M. Karsak, E. Gaffal, R. Date, L. Wang-Eckhardt, J. Rehnelt, and S. Petrosino Attenuation of allergic contact dermatitis through the endocannabinoid system Science 316 2007 1494 1497 (Pubitemid 46906619)
200. 2 receptors in the IgE-mediated triphasic cutaneous reaction in mice Life Sci 80 2007 414 419 (Pubitemid 46013906)
201. 2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice J Immunol 177 2006 8796 8805 (Pubitemid 44893846)
202. 2 exerts antifibrotic effects in experimental dermal fibrosis Arthritis Rheum 60 2009 1129 1136
203. A. Servettaz, N. Kavian, C. Nicco, V. Deveaux, C. Chereau, and A. Wang Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis Am J Pathol 177 2010 187 196
204. D. Richardson, R.G. Pearson, N. Kurian, M.L. Latif, M.J. Garle, and D.A. Barrett Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis Arthritis Res Ther 10 2008 R43
205. S. Yoshihara, H. Morimoto, M. Ohori, Y. Yamada, T. Abe, and O. Arisaka The cannabinoid receptor agonist WIN 55212-2 inhibits neurogenic inflammations in airway tissues J Pharmacol Sci 98 2005 77 82 (Pubitemid 40806130)
206. H. Fukuda, T. Abe, and S. Yoshihara The cannabinoid receptor agonist WIN 55, 212-2 inhibits antigen-induced plasma extravasation in guinea pig airways Int Arch Allergy Immunol 152 2010 295 300
207. C. Blazquez, A. Carracedo, L. Barrado, P.J. Real, J.L. Fernandez-Luna, and G. Velasco Cannabinoid receptors as novel targets for the treatment of melanoma FASEB J 20 2006 2633 2635
208. D. Zheng, A.M. Bode, Q. Zhao, Y.Y. Cho, F. Zhu, and W.Y. Ma The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development Cancer Res 68 2008 3992 3998
209. 2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease Blood 100 2002 627 634 (Pubitemid 34761128)
210. 2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma Endocrinology 151 2010 921 928
211. 2 up-regulation in women affected by endometrial inflammation J Cell Mol Med 12 2008 661 670 (Pubitemid 351555143)
212. H. Xu, C.L. Cheng, M. Chen, A. Manivannan, L. Cabay, and R.G. Pertwee Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis J Leukoc Biol 82 2007 532 541 (Pubitemid 47367143)
213. P. Pacher, S. Batkai, and G. Kunos Cardiovascular pharmacology of cannabinoids Handb Exp Pharmacol 2005 599 625
214. S. Batkai, P. Pacher, D. Osei-Hyiaman, S. Radaeva, J. Liu, and J. Harvey-White Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension Circulation 110 2004 1996 2002 (Pubitemid 39331913)
215. G. Kunos, D. Osei-Hyiaman, J. Liu, G. Godlewski, and S. Batkai Endocannabinoids and the control of energy homeostasis J Biol Chem 283 2008 33021 33025
216. V. Di Marzo The endocannabinoid system in obesity and type 2 diabetes Diabetologia 51 2008 1356 1367
217. G. Kunos, D. Osei-Hyiaman, S. Batkai, K.A. Sharkey, and A. Makriyannis Should peripheral CB(1) cannabinoid receptors be selectively targeted for therapeutic gain? Trends Pharmacol Sci 30 2009 1 7
218. P. Mukhopadhyay, B. Horvath, M. Rajesh, S. Matsumoto, K. Saito, and S. Batkai Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury Free Radic Biol Med 50 1 2011 179 195
219. 1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice Arterioscler Thromb Vasc Biol 29 2009 12 18
220. 1 receptor antagonists for atherosclerosis and cardiometabolic disorders: new hopes, old concerns? Arterioscler Thromb Vasc Biol 29 2009 7 9
221. F. Mach, F. Montecucco, and S. Steffens Cannabinoid receptors in acute and chronic complications of atherosclerosis Br J Pharmacol 153 2008 290 298
222. P. Lepicier, A. Bibeau-Poirier, C. Lagneux, M.J. Servant, and D. Lamontagne Signaling pathways involved in the cardioprotective effects of cannabinoids J Pharmacol Sci 102 2006 155 166 (Pubitemid 44690972)
223. C.R. Hiley Endocannabinoids and the heart J Cardiovasc Pharmacol 53 2009 267 276
224. 2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages Cardiovasc Res 84 2009 378 386
225. 2) receptor deficiency reduces the susceptibility of macrophages to oxidized LDL/oxysterol-induced apoptosis J Lipid Res 49 2008 2338 2346
226. 2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null mice Atherosclerosis 213 2010 102 108
227. 2 receptor gene (CNR2) are not associated with myocardial infarction and cardiovascular risk factors Int J Mol Med 22 2008 165 174
228. Y. Avraham, O. Zolotarev, N.C. Grigoriadis, T. Poutahidis, I. Magen, and L. Vorobiav Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice Am J Gastroenterol 103 2008 3047 3056
229. 1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis Nat Med 12 2006 671 676 (Pubitemid 43865236)
230. M. Domenicali, P. Caraceni, F. Giannone, A.M. Pertosa, A. Principe, and A. Zambruni Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis Gastroenterology 137 2009 341 349
231. P. Pacher, A. Nivorozhkin, and C. Szabo Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol Pharmacol Rev 58 2006 87 114
232. D. Hall, C. Poussin, V.R. Velagapudi, C. Empsen, M. Joffraud, and J. Beckmann Peroxisomal and microsomal lipid pathways associated with resistance to hepatic steatosis and reduced pro-inflammatory state J Biol Chem 285 40 2010 31011 31023
233. S.V. Siegmund, T. Qian, S. de Minicis, J. Harvey-White, G. Kunos, and K.Y. Vinod The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species FASEB J 21 2007 2798 2806 (Pubitemid 47372747)
234. R. Pandey, V.L. Hegde, N.P. Singh, L. Hofseth, U. Singh, and S. Ray Use of cannabinoids as a novel therapeutic modality against autoimmune hepatitis Vitam Horm 81 2009 487 504
235. 1 receptors, and liver disease: hitting more than one bird with the same stone Gastroenterology 134 2008 622 625 (Pubitemid 351173070)
236. G. Kunos, D. Osei-Hyiaman, S. Batkai, and B. Gao Cannabinoids hurt, heal in cirrhosis Nat Med 12 2006 608 610 (Pubitemid 43869936)
237. J. Tam, J. Liu, B. Mukhopadhyay, R. Cinar, G. Godlewski, and G. Kunos Endocannabinoids in liver disease Hepatology 53 1 2011 346 355
238. K.D. Patel, J.S. Davison, Q.J. Pittman, and K.A. Sharkey Cannabinoid CB(2) receptors in health and disease Curr Med Chem 17 2010 1393 1410
239. D.G. Deutsch, M.S. Goligorsky, P.C. Schmid, R.J. Krebsbach, H.H. Schmid, and S.K. Das Production and physiological actions of anandamide in the vasculature of the rat kidney J Clin Invest 100 1997 1538 1546 (Pubitemid 27425781)
240. 1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats Kidney Int 72 2007 1345 1357 (Pubitemid 350126778)
241. G. Karsenty The complexities of skeletal biology Nature 423 2003 316 318 (Pubitemid 40852704)
242. J.B. Lian, A. Javed, S.K. Zaidi, C. Lengner, M. Montecino, and A.J. van Wijnen Regulatory controls for osteoblast growth and differentiation: role of Runx/Cbfa/AML factors Crit Rev Eukaryot Gene Expr 14 2004 1 41 (Pubitemid 38581526)
243. 1 receptor regulates bone formation by modulating adrenergic signaling FASEB J 22 2008 285 294
244. F. Rossi, D. Siniscalco, L. Luongo, L. De Petrocellis, G. Bellini, and S. Petrosino The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption Bone 44 2009 476 484
245. Rossi F, Bellini G, Luongo L, Torella M, Mancusi S, De Petrocellis L, et al. The endovanilloid/endocannabinoid system: a new potential target for osteoporosis therapy. Bone, in press. doi:10.1016/j.bone.2011.01.001.
246. Y. Yamada, F. Ando, and H. Shimokata Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men Int J Mol Med 19 2007 791 801
247. D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanus, A. Breuer, and R. Mechoulam An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 2001 527 531 (Pubitemid 32938751)
248. C. Pope, R. Mechoulam, and L. Parsons Endocannabinoid signaling in neurotoxicity and neuroprotection Neurotoxicology 31 5 2010 562 571
249. Y. Sarne, and R. Mechoulam Cannabinoids: between neuroprotection and neurotoxicity Curr Drug Targets CNS Neurol Disord 4 2005 677 684 (Pubitemid 41782629)
250. 2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study Synapse 53 2004 208 213 (Pubitemid 39045539)
251. C. Benito, E. Nunez, M.R. Pazos, R.M. Tolon, and J. Romero The endocannabinoid system and Alzheimer's disease Mol Neurobiol 36 2007 75 81 (Pubitemid 351360357)
252. E. Nunez, C. Benito, R.M. Tolon, C.J. Hillard, W.S. Griffin, and J. Romero Glial expression of cannabinoid CB(2) receptors and fatty acid amide hydrolase are beta amyloid-linked events in Down's syndrome Neuroscience 151 2008 104 110
253. 2 receptor in the brain Neurosci Lett 412 2007 114 117 (Pubitemid 46074356)
254. 2 receptor agonism protects central neurons from remote axotomy-induced apoptosis through the PI3K/Akt pathway J Neurosci 29 2009 4564 4570
255. 2 cannabinoid agonists stimulate neural progenitor proliferation FASEB J 20 2006 2405 2407
256. G. Esposito, T. Iuvone, C. Savani, C. Scuderi, D. De Filippis, and M. Papa Opposing control of cannabinoid receptor stimulation on amyloid-beta-induced reactive gliosis: in vitro and in vivo evidence J Pharmacol Exp Ther 322 2007 1144 1152 (Pubitemid 47295817)
257. R.A. Sewell, M. Ranganathan, and D.C. D'Souza Cannabinoids and psychosis Int Rev Psychiatry 21 2009 152 162
258. P.D. Morrison, V. Zois, D.A. McKeown, T.D. Lee, D.W. Holt, and J.F. Powell The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning Psychol Med 39 2009 1607 1616
259. D. Koethe, A. Giuffrida, D. Schreiber, M. Hellmich, F. Schultze-Lutter, and S. Ruhrmann Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis Br J Psychiatry 194 2009 371 372
260. J.J. Moreau de Tours Lypermanie avec stupeur; tendence a la demence-traitment par l'extract de cannabis sativa Lancette Gazette Hopital 30 1857 391
261. E. Sulcova, R. Mechoulam, and E. Fride Biphasic effects of anandamide Pharmacol Biochem Behav 59 1998 347 352 (Pubitemid 28072727)
262. R.A. Mangieri, and D. Piomelli Enhancement of endocannabinoid signaling and the pharmacotherapy of depression Pharmacol Res 56 2007 360 366 (Pubitemid 350026393)
263. M.N. Hill, and B.B. Gorzalka Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav Pharmacol 16 2005 333 352 (Pubitemid 41404805)
264. 1 cannabinoid receptors in emotional behaviour Psychopharmacology (Berl) 159 2002 379 387 (Pubitemid 34143362)
265. 1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims Mol Psychiatry 9 2004 184 190 (Pubitemid 38299532)
266. J.P. Despres, A. Golay, and L. Sjostrom Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia N Engl J Med 353 2005 2121 2134 (Pubitemid 41653104)
267. 2 receptors in brain Ann NY Acad Sci 1074 2006 514 536 (Pubitemid 44532857)
268. M. Patel, B. Gomes, C. Patel, and B.C. Yoburn Antagonist-induced micro-opioid receptor up-regulation decreases G-protein receptor kinase-2 and dynamin-2 abundance in mouse spinal cord Eur J Pharmacol 446 2002 37 42 (Pubitemid 34722555)
269. T.W. Pace, and A.H. Miller Cytokines and glucocorticoid receptor signaling. Relevance to major depression Ann NY Acad Sci 1179 2009 86 105
270. 1 receptor antagonists in major depressive disorders Trends Pharmacol Sci 26 2005 609 617 (Pubitemid 41636305)
271. A. Telek, T. Biro, E. Bodo, B.I. Toth, I. Borbiro, and G. Kunos Inhibition of human hair follicle growth by endo- and exocannabinoids FASEB J 21 2007 3534 3541 (Pubitemid 350075143)
272. N. Dobrosi, B.I. Toth, G. Nagy, A. Dozsa, T. Geczy, and L. Nagy Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling FASEB J 22 2008 3685 3695
273. 1 receptor-dependent inhibition of protein kinase C, activation protein-1, and transglutaminase J Biol Chem 278 2003 33896 33903 (Pubitemid 37553223)
274. 1 receptor-dependent manner J Biol Chem 283 2008 6005 6012
275. M.L. Casanova, C. Blazquez, J. Martinez-Palacio, C. Villanueva, M.J. Fernandez-Acenero, and J.W. Huffman Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors J Clin Invest 111 2003 43 50 (Pubitemid 36134847)
276. 2) on sensory nerve fibers and adnexal structures in human skin J Dermatol Sci 38 2005 177 188 (Pubitemid 40779571)
277. 1 receptor antagonist with in vivo antiobesity effect Bioorg Med Chem Lett 19 2009 2546 2550
278. Y. Ueda, N. Miyagawa, T. Matsui, T. Kaya, and H. Iwamura Involvement of cannabinoid CB(2) receptor-mediated response and efficacy of cannabinoid CB(2) receptor inverse agonist, JTE-907, in cutaneous inflammation in mice Eur J Pharmacol 520 2005 164 171 (Pubitemid 41375825)
279. E. Kozela, M. Pietr, A. Juknat, N. Rimmerman, R. Levy, and Z. Vogel Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells J Biol Chem 285 2010 1616 1626
280. Braun A, Engel T, Aguilar-Pimentel JA, Zimmer A, Jakob T, Behrendt H, et al. Beneficial effects of cannabinoids (CB) in a murine model of allergen-induced airway inflammation: role of CB(1)/CB(2) receptors. Immunobiology, in press. doi:10.1016/j.imbio.2010.09.004.
281. T.R. Jan, A.K. Farraj, J.R. Harkema, and N.E. Kaminski Attenuation of the ovalbumin-induced allergic airway response by cannabinoid treatment in A/J mice Toxicol Appl Pharmacol 188 2003 24 35 (Pubitemid 36369386)
282. D. De Filippis, A. D'Amico, and T. Iuvone Cannabinomimetic control of mast cell mediator release: new perspective in chronic inflammation J Neuroendocrinol 20 Suppl. 1 2008 20 25 (Pubitemid 351552672)
283. C. Li, J.E. Bowe, P.M. Jones, and S.J. Persaud Expression and function of cannabinoid receptors in mouse islets Islets 2 2010 293 302
284. C. Li, P.M. Jones, and S.J. Persaud Cannabinoid receptors are coupled to stimulation of insulin secretion from mouse MIN6 beta-cells Cell Physiol Biochem 26 2010 187 196
285. J. Gertsch, R.G. Pertwee, and V. Di Marzo Phytocannabinoids beyond the Cannabis plant - do they exist? Br J Pharmacol 160 2010 523 529
286. J. Gertsch, M. Leonti, S. Raduner, I. Racz, J.Z. Chen, and X.Q. Xie Beta-caryophyllene is a dietary cannabinoid Proc Natl Acad Sci USA 105 26 2008 9099 9104